Commercial production

Emergent BioSolutions manufactures a portfolio of branded protein therapeutics and contract manufactured products at its Winnipeg, Canada site. In 2019, they transitioned their commercial drug products to Cytiva's gloveless filling platform, the SA25 Aseptic Filling Workcell.

Gloveless, robotic control of the SA25 Aseptic Filling Workcell

Resources

Customer story: Amgen

Amgen’s assessment of the SA25 Aseptic Filling Workcell as a next-generation filling system.

Vial, syringes and cartridge filling on the SA25 Aseptic Filling Workcell.

Gain speed to GMP filling

Learn how aseptic filling technology can give you speed advantage to GMP filling

Customer story: WuXi Biologics

This CDMO reached its first GMP batch release 15 months after purchasing a workcell from Cytiva.

Closed robotic workcells

Learn how they differ from conventional systems and how your drug product operations can benefit.

For clinical trials and product development

Moderna is using an SA25 Aseptic Filling Workcell from Cytiva at its Norwood, Massachusetts site for both clinical trial supply manufacturing and product development.

Cytiva SA25 Aseptic Filling Workcell installed in a pharmaceutical cleanroom

Gaining control for gene-edited therapies

Locus Biosciences is taking the fight against antibiotic-resistant bacteria using CRISPR-Cas3 gene-edited therapies. They chose the Microcell™ Vial Filler to gain control over their processes.